PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Total liabilities 2022–2025
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) total liabilities at each fiscal year-end, per SEC filings.
$7.0MFY2025 · since FY2022: $8.3M → $7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.0M | +0.4% |
| FY2024 | $7.0M | -22.9% |
| FY2023 | $9.0M | +9.4% |
| FY2022 | $8.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice